Ascenta Capital

Venture capital firm

Portfolio

1 total

Co-Investors

7

Atlas Venture · 1 shared Cormorant Asset Management · 1 shared Deep Track Capital · 1 shared Fidelity Management & Research · 1 shared Janus Henderson Investors · 1 shared OrbiMed · 1 shared Viking Global Investors · 1 shared

Latest Pulse

Jun 18, 2026Triveni Bio Raises $65M for Antibody Therapeutics in ImmunologyTriveni Bio raised $65 million, co-led by Ascenta Capital and Janus Henderson Investors, to advance antibody-based therapeutics for immunological and inflammatory diseases. The round is a reminder that biotech capital is still flowing to differentiated science even in an AI-dominated market.→
Jun 17, 2026Triveni Bio Raises $65M for Antibody-Based Immunology TherapeuticsTriveni Bio raised $65 million co-led by Ascenta Capital and Janus Henderson to advance antibody-based therapeutics targeting immunological diseases. The round is part of a biotech rebound that's running alongside the AI-infrastructure boom rather than being crowded out by it.→

Suggest a correction